insights_auto
Why is BOT up 5,56%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
0,019 A$
arrow_upward
+5,56%(+0,0010) 1D
1 հոկ, 16:10:19 GMT+10 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
0,02 A$
High
0,02 A$
Low
0,02 A$
Mkt. cap
47,22 մլն
Avg. vol.
5,84 մլն
Volume
15,48 մլն
52-wk high
0,17 A$
52-wk low
0,02 A$
EPS
-0,03 A$
Shares outstanding
2,76 մլրդ
No. of employees
11
Open
0,02 A$
High
0,02 A$
Low
0,02 A$
Mkt. cap
47,22 մլն
Avg. vol.
5,84 մլն
Volume
15,48 մլն
52-wk high
0,17 A$
52-wk low
0,02 A$
EPS
-0,03 A$
Shares outstanding
2,76 մլրդ
No. of employees
11
News stories
From web sources and news partners
MarketBeat
·
5 րոպե առաջ
Commerce Bancshares, Inc. (NASDAQ:CBSH) Stock Has Average Price Target of $64.71
Stocktwits
·
1 ժամ առաջ
Most S&P 500 Stocks Sank In September — But Retail Traders Didn't Flee
Bloomberg.com
·
53 րոպե առաջ
Asian Stocks Eye Rough Start After US Reversal: Markets Wrap
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd